Tag Archives: biology

Spit it out! How nature joins up with rodents.

Technion researchers discover how the defensive chemicals of a fruit turn a seed predator into a quality seed disperser.

Researchers from the Technion Faculty of Biology have discovered how fruit chemistry alters animal behavior. The researchers found a chemical mechanism that encourages seed dispersal in the fruit of the desert plant ‘sweet mignonette’ or ‘taily weed’.

This mechanism contains stable, non-toxic substances called glucosinolates, which are found only in the fruit pulp and break down into toxic products when the seed, which contains the enzyme myrosinase, is damaged mechanically. Apparently, the compartmentalization of glucosinolates and myrosinase in the fruits of sweet mignonette affects the interaction between the plant and rodents that are known to be seed predators. One of the rodents examined, the common spiny mouse, was even found to be a quality dispenser of the sweet mignonette seeds. This is the first documentation of a chemical mechanism in fruits that encourages seed dispersal by mammals.

According to the directed deterrence hypothesis, defensive chemicals (secondary metabolites) in ripe fruits deter seed predators, but have no or little effect on seed dispersers. Indeed, there is some evidence that birds (seed dispersers) and mammals (seed predators) differ in their responses to defensive chemicals. However, this mechanism was only demonstrated based on differences at the class level, namely differences in vanilloid receptors found in mammals but not in birds.  

“Here we present the findings of physiological and behavioral experiments demonstrating the use of defensive chemicals of the mustard oil bomb to encourage broad-range, class-independent (e.g. mammals vs. birds) seed dispersal in sweet mignonette fruits, in order to force a behavioral change at an ecological timescale, converting rodents from seed predators to seed dispersers,”  writes researcher Michal Samuni-Blank, who was supervised by Profs. Zeev Arad of the Technion and Ido Izhaki of Haifa University.

“This change is achieved through the unique compartmentalization of the mustard oil bomb, which causes activation of the system only upon seed and pulp co-consumption. This ‘motivates’ seed dispersal which has led to the first ever documentation of a rodent dispersing seeds via seed spitting”.

The research findings demonstrate the power of fruits defensive chemicals to shift the animal-plant relationships from predation to mutualism, and supports the directed deterrence hypothesis at the intraspecific level, in addition to the interspecific level.

Outsmarting HIV with X-Ray Crystallography

Dr, Alian Akram, Lorry I. Lokey Center for Life Science & Engineering, Technion.

Outsmarting HIV


It sound like modern warfare, and indeed, even when aiming to outsmart a killer virus on a scale of about 100 nanometers, the latest technology makes all the difference. One of the deep passions behind Dr. Alian Akram’s pioneering crystallographic work in the Technion is a desire to advance treatments for HIV, the causative agent of AIDS.



Scientists in Akram’s lab investigate the general principles of how aggressive virus lock into the genetic resources of a patient – and how to prevent them from doing this. “It is a MUST to learn about the critical interactions and the mechanisms of resistance,” says Akram. The team is taking a sharp look at pathogen-host interaction and how the HIV virus literally hijacks the machinery of the host cell in order to replicate itself, and how it escapes the immune system. “We are hoping to determine the structures of key interacting molecules and develop new intervening strategies and drugs that prevent their interaction. We also want to understand the mechanism of emergent resistance in the proteins of this virus.”



Current drugs for HIV bind viral proteins – and yet it continues to mutate and regenerate. Akram’s team is working on a protein discovered in 2004 – intrinsic immunity APOBEC3G. This protein attacks the genome of HIV and causes hypermutation that leads to an abortive replication cycle for HIV. However, HIV expresses a protein that destroys APOBEC, so the Akram’s group wants to understand this process better so that it can be blocked.
Crystal structure of Pseudouridine synthase in complex with RNA solved by  Akram Alian. The structure reveals base-pair rearrangement as the key mechanism to rRNA substrate selectivity  (http://rnajournal.cshlp.org/content/16/6.cover-expansion)”

Outsmarting HIV with X-Ray Crystallography

Dr, Alian Akram, Lorry I. Lokey Center for Life Science & Engineering, Technion.

Outsmarting HIV


It sound like modern warfare, and indeed, even when aiming to outsmart a killer virus on a scale of about 100 nanometers, the latest technology makes all the difference. One of the deep passions behind Dr. Alian Akram’s pioneering crystallographic work in the Technion is a desire to advance treatments for HIV, the causative agent of AIDS.



Scientists in Akram’s lab investigate the general principles of how aggressive virus lock into the genetic resources of a patient – and how to prevent them from doing this. “It is a MUST to learn about the critical interactions and the mechanisms of resistance,” says Akram. The team is taking a sharp look at pathogen-host interaction and how the HIV virus literally hijacks the machinery of the host cell in order to replicate itself, and how it escapes the immune system. “We are hoping to determine the structures of key interacting molecules and develop new intervening strategies and drugs that prevent their interaction. We also want to understand the mechanism of emergent resistance in the proteins of this virus.”



Current drugs for HIV bind viral proteins – and yet it continues to mutate and regenerate. Akram’s team is working on a protein discovered in 2004 – intrinsic immunity APOBEC3G. This protein attacks the genome of HIV and causes hypermutation that leads to an abortive replication cycle for HIV. However, HIV expresses a protein that destroys APOBEC, so the Akram’s group wants to understand this process better so that it can be blocked.
Crystal structure of Pseudouridine synthase in complex with RNA solved by  Akram Alian. The structure reveals base-pair rearrangement as the key mechanism to rRNA substrate selectivity  (http://rnajournal.cshlp.org/content/16/6.cover-expansion)”

Technion LIVE e-newsletter December 2011, breaking science & technology news from Israel

December 2011
Alzheimer’s Drug Development Microsoft Joins Technion Solar Nano Power Nobel Prize 2011

From the President

On the eve of the awarding of the 2011 Nobel Prize in Chemistry to Distinguished Professor Dan Shechtman – the third Technion professor to win a Nobel in 7 years – we are excited to welcome you to this edition of Technion Live. The Technion remains active in its quest to meet the scientific, technological, economic and social challenges of the future. These are matters of science and technology, but also of nurturing a sensitivity to social tensions and the needs of the wider community.
Technion is an exemplary model of providing equal opportunity to the various sectors of Israeli society, as seen in our film Partners in Progress. We are also proud to announce the launch of an undergraduate degree program to serve the orthodox community in Bnei Brak. The ingenuity of staff and students in answering the credit crunch with a scheme for exchanging books at bus stops (bookshops at bus shelters) – has already been applied by several municipalities.
On the eve of our cornerstone centennial, our pride and our hopes for the future are shared by the whole Technion community of students, faculty, friends and supporters. Together, we have the means, ingenuity and willpower to make our world a better place.

Technion President
Prof. Peretz Lavie

Nobel Prize 2011: Live Events
On 10th December, 2011 Distinguished Prof. Dan Shechtman, holder of the Philip Tobias Chair, will receive the Nobel Prize in Chemistry. Join us for live coverage in Israel and Sweden!
The Quasi Caucus
Science is a process of evolution as the community of scientists work together, each building on the discoveries of the ones that went before. Thus, Shechtman’s discovery of quasicrystals didn’t negate the existing science of crystallography, but reopened the field of materials science to new exploration. Soon after his discovery, a league of gifted scientists stepped in to substantiate the breakthrough and to take it forward.
A Whole New Matter
A look at one of the applications of the quasicrystal discovery – this time at the unique qualities of quasicrystals as transporters of light. The groundbreaking photonic research was published by Distinguished Prof. Mordechai Segev and his team at the Technion Faculty of Physics.
Tie/Scarf competition
A new trend among world intelligentsia is to acquire and wear the now famous 100% silk quasicrystal tie, as worn by Prof. Shechtman, President Peretz Lavie and Prime Minister of the State of Israel Benjamin Netanyahu. This is your chance to win one too, or a silk quasicrystal scarf for women. Just compose a clever message about the 2011 Nobel Prize in Chemistry and post it at one of our many social media venues.
On Screen
Phone call from Stockholm
Oct. 5, 2011 the telephone rings, Stockholm calling… Technion Distinguished Prof. Dan Shechtman has been named as this year’s Nobel laureate in Chemistry. Share the initial excitement and celebrations – including a science lesson for Israel’s Prime Minister Benjamin Netanyahu.
Partners in Progress
For the past decade, the Landa Equal Opportunities Project has successfully prepared Israeli Arab students to excel at Technion, fully integrating them into the Technion community.
Israel’s Titan
Technion is home to Israel’s only Titan – Transmission Electron Microscope. Prof. Wayne Kaplan, dean of the department of Materials Engineering explains how something so large is needed to examine the dimensions of the tiny.
Mechanics of the Millennium
From developing robots that perform surgeries, designing renewable energy systems, manufacturing machines smaller than the human hair (nano mechanics), and integrating optical systems, to developing giant printers and advanced aircraft, a visit to the Faculty of Mechanical Engineering unveils the future.
Ivy League & Israel
“Like Cornell, Technion looks beyond borders. In its mission statement, it is “dedicated to the creation of knowledge and the development of human capital and leadership, for the advancement of the State of Israel and all humanity.” Read more about what the partners in the bid of the New York City Tech Campus have in common.

(l-r) Presidents David J. Skorton and Peretz Lavie
Microsoft joins Technion
Through a new five-year joint research and education partnership, Microsoft Research and Technion will explore scientific and technological insights in e-commerce, such as online advertising and the use of social networks for commerce. Microsoft will invest $1.5 million (U.S.) over the next five years.
Bridge to Somewhere
Haaretz reports on the state-of-the-art in graduate student accommodation at the Stanley Shalom Zielony Graduate Student Village, Technion City.
Cancer Cells on the Run
Researchers from Technion and Utrecht University in the Netherlands show that chemotherapy drugs can increase the risk of a metastatic process in mice.
Dr. Yuval Shaked of the Technion and Prof. Emile Voest of Utrecht University published their findings in the scientific journal, Cancer Research.
Solar power – Nano power
Technion researchers polarize a nanometric-sized crystal by changing the composition of surrounding molecules. In the future, this could improve efficiency of 3G solar photovoltaic cells.
3 Million to Perfect Alzheimer’s Drug
A consortium of four investors, including the Technion Research and Development Foundation Ltd. (TRDF), has completed a $3 million financing round for Israel-based Avraham Pharmaceuticals to further the development of a novel drug for Alzheimer’s disease.
Remembrance & Redemption
A pioneer in using a shared love of advanced science to heal historic wounds, former Technion President Distinguished Prof. Yitzhak Apeloig from the Schulich Faculty of Chemistry received the Order of Merit (First Degree) of the Federal Republic of Germany at a ceremony held at Technion on November 28, 2011.

(l-r) Distinguished Prof. Yitzhak Apeloig and
H.E. Andreas Michaelis
Harvey Prize Winners
Prof. Sir Richard Friend of the University of Cambridge, UK, and Prof. Judea Pearl from the University of California, Los Angeles, are the winners of the Technion’s 2011 Harvey Prize in Science and Technology. The prize ceremony will take place at Technion, on March 29, 2012.

(l-r) Prof. Sir Richard Friend and Prof. Judea Pearl
People of the Book
Technion Prof. Shlomo Maital looks at the Technion ingenuity behind the new people-generated trend: self-assembling libraries in bus stops across Israel.
Unsubscribe from Technion Live

Technion LIVE e-newsletter December 2011, breaking science & technology news from Israel

December 2011
Alzheimer’s Drug Development Microsoft Joins Technion Solar Nano Power Nobel Prize 2011

From the President

On the eve of the awarding of the 2011 Nobel Prize in Chemistry to Distinguished Professor Dan Shechtman – the third Technion professor to win a Nobel in 7 years – we are excited to welcome you to this edition of Technion Live. The Technion remains active in its quest to meet the scientific, technological, economic and social challenges of the future. These are matters of science and technology, but also of nurturing a sensitivity to social tensions and the needs of the wider community.
Technion is an exemplary model of providing equal opportunity to the various sectors of Israeli society, as seen in our film Partners in Progress. We are also proud to announce the launch of an undergraduate degree program to serve the orthodox community in Bnei Brak. The ingenuity of staff and students in answering the credit crunch with a scheme for exchanging books at bus stops (bookshops at bus shelters) – has already been applied by several municipalities.
On the eve of our cornerstone centennial, our pride and our hopes for the future are shared by the whole Technion community of students, faculty, friends and supporters. Together, we have the means, ingenuity and willpower to make our world a better place.

Technion President
Prof. Peretz Lavie

Nobel Prize 2011: Live Events
On 10th December, 2011 Distinguished Prof. Dan Shechtman, holder of the Philip Tobias Chair, will receive the Nobel Prize in Chemistry. Join us for live coverage in Israel and Sweden!
The Quasi Caucus
Science is a process of evolution as the community of scientists work together, each building on the discoveries of the ones that went before. Thus, Shechtman’s discovery of quasicrystals didn’t negate the existing science of crystallography, but reopened the field of materials science to new exploration. Soon after his discovery, a league of gifted scientists stepped in to substantiate the breakthrough and to take it forward.
A Whole New Matter
A look at one of the applications of the quasicrystal discovery – this time at the unique qualities of quasicrystals as transporters of light. The groundbreaking photonic research was published by Distinguished Prof. Mordechai Segev and his team at the Technion Faculty of Physics.
Tie/Scarf competition
A new trend among world intelligentsia is to acquire and wear the now famous 100% silk quasicrystal tie, as worn by Prof. Shechtman, President Peretz Lavie and Prime Minister of the State of Israel Benjamin Netanyahu. This is your chance to win one too, or a silk quasicrystal scarf for women. Just compose a clever message about the 2011 Nobel Prize in Chemistry and post it at one of our many social media venues.
On Screen
Phone call from Stockholm
Oct. 5, 2011 the telephone rings, Stockholm calling… Technion Distinguished Prof. Dan Shechtman has been named as this year’s Nobel laureate in Chemistry. Share the initial excitement and celebrations – including a science lesson for Israel’s Prime Minister Benjamin Netanyahu.
Partners in Progress
For the past decade, the Landa Equal Opportunities Project has successfully prepared Israeli Arab students to excel at Technion, fully integrating them into the Technion community.
Israel’s Titan
Technion is home to Israel’s only Titan – Transmission Electron Microscope. Prof. Wayne Kaplan, dean of the department of Materials Engineering explains how something so large is needed to examine the dimensions of the tiny.
Mechanics of the Millennium
From developing robots that perform surgeries, designing renewable energy systems, manufacturing machines smaller than the human hair (nano mechanics), and integrating optical systems, to developing giant printers and advanced aircraft, a visit to the Faculty of Mechanical Engineering unveils the future.
Ivy League & Israel
“Like Cornell, Technion looks beyond borders. In its mission statement, it is “dedicated to the creation of knowledge and the development of human capital and leadership, for the advancement of the State of Israel and all humanity.” Read more about what the partners in the bid of the New York City Tech Campus have in common.

(l-r) Presidents David J. Skorton and Peretz Lavie
Microsoft joins Technion
Through a new five-year joint research and education partnership, Microsoft Research and Technion will explore scientific and technological insights in e-commerce, such as online advertising and the use of social networks for commerce. Microsoft will invest $1.5 million (U.S.) over the next five years.
Bridge to Somewhere
Haaretz reports on the state-of-the-art in graduate student accommodation at the Stanley Shalom Zielony Graduate Student Village, Technion City.
Cancer Cells on the Run
Researchers from Technion and Utrecht University in the Netherlands show that chemotherapy drugs can increase the risk of a metastatic process in mice.
Dr. Yuval Shaked of the Technion and Prof. Emile Voest of Utrecht University published their findings in the scientific journal, Cancer Research.
Solar power – Nano power
Technion researchers polarize a nanometric-sized crystal by changing the composition of surrounding molecules. In the future, this could improve efficiency of 3G solar photovoltaic cells.
3 Million to Perfect Alzheimer’s Drug
A consortium of four investors, including the Technion Research and Development Foundation Ltd. (TRDF), has completed a $3 million financing round for Israel-based Avraham Pharmaceuticals to further the development of a novel drug for Alzheimer’s disease.
Remembrance & Redemption
A pioneer in using a shared love of advanced science to heal historic wounds, former Technion President Distinguished Prof. Yitzhak Apeloig from the Schulich Faculty of Chemistry received the Order of Merit (First Degree) of the Federal Republic of Germany at a ceremony held at Technion on November 28, 2011.

(l-r) Distinguished Prof. Yitzhak Apeloig and
H.E. Andreas Michaelis
Harvey Prize Winners
Prof. Sir Richard Friend of the University of Cambridge, UK, and Prof. Judea Pearl from the University of California, Los Angeles, are the winners of the Technion’s 2011 Harvey Prize in Science and Technology. The prize ceremony will take place at Technion, on March 29, 2012.

(l-r) Prof. Sir Richard Friend and Prof. Judea Pearl
People of the Book
Technion Prof. Shlomo Maital looks at the Technion ingenuity behind the new people-generated trend: self-assembling libraries in bus stops across Israel.
Unsubscribe from Technion Live

Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium

Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium

“Now we can understand, at least partially, many natural programs that have not yet been decoded by simply reading the DNA sequence.”
Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium. They hope that in the future this will enable the translation of the genome’s “operating system”; they are working in the new field of synthetic biology and believe that this will be “the high tech of bio tech”.
The prestigious science journal, Cell, reports that Technion researchers in collaboration with Caltech researchers have successfully built a “biological Rosetta Stone” within a bacterium, by developing a new understanding of the group of bacterial regulators called Enhancers. These objects encompass non-gene coding sequences on DNA, to which proteins attach. These objects function by integrating several proteins, and upon reaching the correct combination, the target gene is expressed. By learning how to “program” these enhancer, the researchers hope to gain a more precise control of gene expression.

“One of the central discoveries in biology in the post-genome era is the understanding that the main factors contributing to the differences between organisms (for instance, between mice and men) is not the result of genes,” explains Dr. Roee Amit of the Faculty of Biotechnology and Food Engineering at the Technion, who began his research as part of a post-doctoral fellowship at Caltech. “The origin of this difference is in the algorithm or program that determines when, where and how any gene will be expressed. In the past few years a new picture of the genome is becoming clearer, and as a result, also a model in which the genome is perceived as a complex tool for storage and dissemination of information.”

The objective of the Technion researchers is to decode the “software” that controls the process and use this knowledge to develop medical applications. “In order to do this, we intend to create a ‘Rosetta Stone’ for the gene regulatory code (the original Rosetta Stone is a granodiorite stele that had the same ancient text inscribed on it in three different languages, as a result of which archaeologists were able to decipher Egyptian hieroglyphics),” says Dr. Amit.

“This tool will be used to ‘hack’ the control program of real organisms and consequently allow us to ‘write’ new programs – which do not exist in nature – for medical purposes, environmental applications, etc. Synthetic biology is a new branch of life science, which takes a constructive/building approach. It attempts to use biological components to construct new biological systems that do not exist in nature. It forces us to really examine our understanding by requiring us to use what we think we understand in order to create biological functions. It allows us to ask why evolution “locked onto” specific patterns, to imagine and create new biological functions and forces us to work in a multidisciplinary fashion.”

The approach of researchers in synthetic biology is based on using characteristic genomic components and arranging them together (or “wiring” them to each other) in new architectures. In the next stage they develop patterns based on thermodynamic models, and in the end, they analyze the output using their model. By doing this, they can draw basic programming principles that permit them to translate the architecture and the sequence into computer algorithms. “If we succeed in writing a sequence that predicts our output based on computerized rules that we found in the ‘Rosetta Stone’ – we can then use this ‘key’ to decipher certain sequences that appear in the genome,” says Dr. Amit.
In the paper appearing in Cell, the Technion researchers show that they can use this approach to develop a new understanding of enhancers among bacteria. These sequences are common to all living creatures and may be thought of as modular objects that can combine “input” or signals. Because bacterial enhancers have a simpler architecture and at times it is easier to characterize them, the Technion researchers chose to focus on them first. The researches demonstrated the possibility of building new bacterial enhancer programs that will lead to a physical model of the control program, or to the “machine code”. The researchers note that the type of computerization that takes place in this context is reminiscent of analogue computing processes more than digital ones.
“This Rosetta Stone, in the bacterial context, has enabled us to formulate a new understanding, or qualitative model, for many examples of bacterial enhancers in nature, most of which have never been analyzed,” stresses Dr. Amit. “Now we can understand, at least partially, many natural programs that have not yet been decoded by simply reading the DNA sequence.”

Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium

Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium

“Now we can understand, at least partially, many natural programs that have not yet been decoded by simply reading the DNA sequence.”
Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium. They hope that in the future this will enable the translation of the genome’s “operating system”; they are working in the new field of synthetic biology and believe that this will be “the high tech of bio tech”.
The prestigious science journal, Cell, reports that Technion researchers in collaboration with Caltech researchers have successfully built a “biological Rosetta Stone” within a bacterium, by developing a new understanding of the group of bacterial regulators called Enhancers. These objects encompass non-gene coding sequences on DNA, to which proteins attach. These objects function by integrating several proteins, and upon reaching the correct combination, the target gene is expressed. By learning how to “program” these enhancer, the researchers hope to gain a more precise control of gene expression.

“One of the central discoveries in biology in the post-genome era is the understanding that the main factors contributing to the differences between organisms (for instance, between mice and men) is not the result of genes,” explains Dr. Roee Amit of the Faculty of Biotechnology and Food Engineering at the Technion, who began his research as part of a post-doctoral fellowship at Caltech. “The origin of this difference is in the algorithm or program that determines when, where and how any gene will be expressed. In the past few years a new picture of the genome is becoming clearer, and as a result, also a model in which the genome is perceived as a complex tool for storage and dissemination of information.”

The objective of the Technion researchers is to decode the “software” that controls the process and use this knowledge to develop medical applications. “In order to do this, we intend to create a ‘Rosetta Stone’ for the gene regulatory code (the original Rosetta Stone is a granodiorite stele that had the same ancient text inscribed on it in three different languages, as a result of which archaeologists were able to decipher Egyptian hieroglyphics),” says Dr. Amit.

“This tool will be used to ‘hack’ the control program of real organisms and consequently allow us to ‘write’ new programs – which do not exist in nature – for medical purposes, environmental applications, etc. Synthetic biology is a new branch of life science, which takes a constructive/building approach. It attempts to use biological components to construct new biological systems that do not exist in nature. It forces us to really examine our understanding by requiring us to use what we think we understand in order to create biological functions. It allows us to ask why evolution “locked onto” specific patterns, to imagine and create new biological functions and forces us to work in a multidisciplinary fashion.”

The approach of researchers in synthetic biology is based on using characteristic genomic components and arranging them together (or “wiring” them to each other) in new architectures. In the next stage they develop patterns based on thermodynamic models, and in the end, they analyze the output using their model. By doing this, they can draw basic programming principles that permit them to translate the architecture and the sequence into computer algorithms. “If we succeed in writing a sequence that predicts our output based on computerized rules that we found in the ‘Rosetta Stone’ – we can then use this ‘key’ to decipher certain sequences that appear in the genome,” says Dr. Amit.
In the paper appearing in Cell, the Technion researchers show that they can use this approach to develop a new understanding of enhancers among bacteria. These sequences are common to all living creatures and may be thought of as modular objects that can combine “input” or signals. Because bacterial enhancers have a simpler architecture and at times it is easier to characterize them, the Technion researchers chose to focus on them first. The researches demonstrated the possibility of building new bacterial enhancer programs that will lead to a physical model of the control program, or to the “machine code”. The researchers note that the type of computerization that takes place in this context is reminiscent of analogue computing processes more than digital ones.
“This Rosetta Stone, in the bacterial context, has enabled us to formulate a new understanding, or qualitative model, for many examples of bacterial enhancers in nature, most of which have never been analyzed,” stresses Dr. Amit. “Now we can understand, at least partially, many natural programs that have not yet been decoded by simply reading the DNA sequence.”